Abstract
Synthesis of 2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG) involving base hydrolysis was optimized. Fluorine-18 was isolated from irradiated water to more than 90% by sorption of [1 8F]fluoride on QMA anion-exchange resin, which was followed by elution with a 96 : 4 (by volume) acetonitrile-water mixture containing Kryptofix 2.2.2 and potassium carbonate (molar ratio 2 : 1). This composition is the best for preparing the complex [K/K2.2.2]+ 18F- used in nucleophilic fluorinations. No additional azeotropic drying is required. Base hydrolysis under optimized conditions (40-45°C), followed by neutralization with HCl, removal of traces of the solvent, and purification of the final product on a combined SCX/Alumina N column, yielded [1 8F]FDG of high radiochemical (>99%) and chemical purity with minimal product loss. With an RB-86 robotic system (Anatech, Sweden), the synthesis time was 38 min. The procedure is used in the Institute of Human Brain, Russian Academy of Sciences for routine synthesis of FDG; the radiochemical yield of the product by the end of synthesis (EOS) is reproducibly high: 63±3% (n = 40).
Similar content being viewed by others
REFERENCES
Meyer, G.-J., Waters, S.L., Coenen, H.H., et al., Eur. J. Nucl. Med., 1995, vol. 22, no. 12, pp. 1420-1432.
Pauwels, E.K.J., Ribeiro, M.J., Stoot, J.H.M.B., et al., Nucl. Med. Biol., 1996, vol. 25, pp. 317-322.
Amano, S., Inoue, T., Tomiyoshi, K., et al., J. Nucl. Med., 1998, vol. 39, pp. 1424-1427.
Coenen, H.H., Pike, V.W., Stocklin, G., and Wagner, R., J. Radiat. Appl. Instrum., Part A, 1987, vol. 38, no. 8, pp. 605-610.
Helus, F., Maier-Borst, W., and Oberdorfer, F., Devel. Nucl. Med., 1992, vol. 27, pp. 235-238.
Beuthien-Baumann, B., Hamacher, K., Oberdorfer, F., and Steinbach, J., Carbohydr. Res., 2000, vol. 327, nos. 1-2, pp. 107-118.
Block, D., Klatte, B., and Knochel, A., J. Label. Comp. Radiopharm., 1986, vol. 23, no. 5, pp. 467-477.
Kilbourn, M.R., Fluorine-18 Labelling of Radiopharmaceuticals, Nuclear Science Ser., Washington: National Academy, 1990.
Hamacher, K., Coenen, H.H., and Stocklin, G., J. Nucl. Med., 1986, vol. 27, pp. 235-238.
Kiselev, M.Yu., Solov'ev, D.V., and Korsakov, M.V., Radiokhimiya, 1992, vol. 34, no. 2, pp. 129-135.
Krasikova, R.N., Radiokhimiya, 1998, vol. 40, no. 4, pp. 352-361.
Fuchtner, F., Steinbach, J., Mading, P., and Johansen, B., Appl. Radiat. Isot., 1996, vol. 47, no. 1, pp. 61-66.
Bogni, A., Pascali, C., Iwata, R., et al., J. Label. Comp. Radiopharm., 1997, vol. 40, pp. 219-221.
Zijlsta, S., Medema, J., Elsinga, P.H., et al., J. Label. Comp. Radiopharm., 1997, vol. 40, suppl. 1, pp. 229-230.
Mosdzianovski, C., Lemaire, C., Lauricella, B., et al., J. Label. Comp. Radiopharm., 1999, vol. 42, suppl. 1, pp. 515-517.
Gomzina, N.A., Krasikova, R.N., Korsakov, M.V., and Dahlstrom, K., Eur. J. Nucl. Med., 2000, vol. 27, no. 8, p. 1220.
Gomzina, N.A., Zaitsev, V.V., and Krasikova, R.N., J. Label. Comp. Radiopharm., 2001, vol. 44, suppl. 1, pp. 515-517.
Studentsov, E.P., Korsakov, M.V., Shchukin, E.V., et al., RF Patent Appl. 2 000 116 601/14.
Korsakov, M.V., Solov'ev, D.V., and Udalov, V.B., Radiokhimiya, 1994, vol. 36, no. 5, pp. 434-439.
Schlyer, D.J., Firouzbakht, M.L., and Wolf, A.P., Appl. Radiat. Isot., 1993, vol. 44, no. 12, pp. 1459-1465.
Proc. Seventh Workshop on the Targetry and Target Chemistry, Heidelberg, 1997, pp. 167-172.
Jewett, D.M., Toorongian, S.A., Bachelor, M.A., and Kilbourn, M.R., Appl. Radiat. Isot., 1990, vol. 41, no. 6, pp. 583-586.
Schlyer, D.J., Bastos, M.A.V., Alexoff, D., and Wolf, A.P., Int. J. Appl. Radiat. Isot., 1990, vol. 41, no. 6, pp. 531-533.
Paskali, C., Bogni, A., Decise, D., et al., Anticancer Res., 1998, vol. 18, pp. 1563-1568.
Znang, Z.Y., Zigler, S.S., and Kabalka, G.W., J. Label. Comp. Radiopharm., 1997, vol. 40, suppl. 1, pp. 286-288.
Channing, M.A., Huang, B.X., and Eckelman, W.C., Nucl. Med. Biol., 2001, vol. 28, pp. 469-471.
Pharmeuropa, 1996, vol. 8, no. 4, pp. 514-517.
Meyer, G.-J., Martzke, K.H., Hamacher, K., et al., Appl. Radiat. Isot., 1999, vol. 51, pp. 37-41.
Varelis, P. and Barnes, R.K., Appl. Radiat. Isot., 1996, vol. 47, no. 8, pp. 731-733.
FSP (Pharmacopoeia Item of Enterprise) 42-0257-1062-01: Fluorodeoxyglucose, 18F: Solution for Injection, Inst. of Human Brain, Russian Acad. Sci., 2001.
Zaitsev, V.V., Fedorova, O.S., Mosevich, I.K., et al., Radiokhimiya, 2002, vol. 44, no. 4, pp. 358-365.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gomzina, N.A., Vasil'ev, D.A. & Krasikova, R.N. Optimization of Automated Synthesis of 2-[18F]Fluoro-2-deoxy-D-glucose Involving Base Hydrolysis. Radiochemistry 44, 403–409 (2002). https://doi.org/10.1023/A:1020689314452
Issue Date:
DOI: https://doi.org/10.1023/A:1020689314452